Study on rTMS for Methamphetamine Abuse in Methadone Patients Launched
A clinical trial is underway to evaluate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) for treating methamphetamine abuse in patients undergoing methadone maintenance therapy.
Phase III
Addiction / Neuromodulation
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing clinical trial on rTMS for methamphetamine abuse in methadone patients could significantly influence treatment protocols in addiction therapies. Success in this trial may lead to new treatment options, impacting portfolio strategies for companies in the neuromodulation and addiction sectors.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent publications regarding the efficacy and safety of rTMS in this context.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.